Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
BackgroundRadiation-induced changes following proton beam therapy in isocitrate dehydrogenase (IDH)-mutated diffuse central nervous system (CNS) World Health Organization (WHO) grade 2 and 3 gliomas are not well characterized. We present a patient with an IDH-mutant astrocytoma CNS WHO grade 3 treat...
Saved in:
Main Authors: | Liv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hanne Blakstad, Cathrine Saxhaug, Pål André Rønning, Pitt Frederik Niehusmann, Katja Werlenius, Malin Blomstrand, Petter Brandal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1397912/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative proteomic analysis of astrocytoma tissues from patients with and without seizures
by: Thanakorn Khaosuwan, et al.
Published: (2025-01-01) -
Pilocytic astrocytoma: A rare case report
by: Harry Galuh Nugraha, PhD, et al.
Published: (2025-04-01) -
Clinicopathological and molecular characterization of astrocytoma
by: Xiaoyan Wu, et al.
Published: (2025-02-01) -
Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
by: Ximu Sun, et al.
Published: (2025-02-01) -
IDH-mutant gliomas in children and adolescents - from biology to clinical trials
by: Louise Evans, et al.
Published: (2025-01-01)